| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Atheroprotective effects and molecular targets of bioactive compounds from traditional Chinese medicine
|
Qiao, Lei
|
|
2018
|
135 |
C |
p. 212-229
|
artikel
|
| 2 |
CHST3 and CHST13 polymorphisms as predictors of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension
|
Yorifuji, Kennosuke
|
|
2018
|
135 |
C |
p. 259-264
|
artikel
|
| 3 |
Corrigendum to “Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia” [Pharmacol. Res. 131 (2018) 66–74]
|
Cangemi, Roberto
|
|
2018
|
135 |
C |
p. 268
|
artikel
|
| 4 |
Corrigendum to “The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis” [Pharmacol. Res. (2018) 102–111]
|
Li, Ya-Kun
|
|
2018
|
135 |
C |
p. 269-270
|
artikel
|
| 5 |
Covered stenting and transcatheter embolization of splenic artery aneurysms in diabetic patients: A review of endovascular treatment of visceral artery aneurysms in the current era
|
Venturini, Massimo
|
|
2018
|
135 |
C |
p. 127-135
|
artikel
|
| 6 |
Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis
|
Cargnin, Sarah
|
|
2018
|
135 |
C |
p. 102-111
|
artikel
|
| 7 |
Dose-dependent target diversion of Danhong injection on the Glu-GLT-1/Gly-GlyRα dynamic balance module of cerebral ischemia
|
Xu, Wenjuan
|
|
2018
|
135 |
C |
p. 80-88
|
artikel
|
| 8 |
Editorial Board
|
|
|
2018
|
135 |
C |
p. ii
|
artikel
|
| 9 |
Effect of statins on toll-like receptors: a new insight to pleiotropic effects
|
Bahrami, Afsane
|
|
2018
|
135 |
C |
p. 230-238
|
artikel
|
| 10 |
Effect of ursodeoxycholic acid on glycemic markers: A systematic review and meta-analysis of clinical trials
|
Sánchez-García, Adriana
|
|
2018
|
135 |
C |
p. 144-149
|
artikel
|
| 11 |
ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR
|
Shao, Zhiyi
|
|
2018
|
135 |
C |
p. 188-200
|
artikel
|
| 12 |
Fraxinellone has anticancer activity in vivo by inhibiting programmed cell death-ligand 1 expression by reducing hypoxia-inducible factor-1α and STAT3
|
Xing, Yue
|
|
2018
|
135 |
C |
p. 166-180
|
artikel
|
| 13 |
From stroke to neurodegenerative diseases: The multi-target neuroprotective effects of 3-n-butylphthalide and its derivatives
|
Huang, Longjian
|
|
2018
|
135 |
C |
p. 201-211
|
artikel
|
| 14 |
Mitochondrial bioenergetics, redox state, dynamics and turnover alterations in renal mass reduction models of chronic kidney diseases and their possible implications in the progression of this illness
|
Aparicio-Trejo, Omar Emiliano
|
|
2018
|
135 |
C |
p. 1-11
|
artikel
|
| 15 |
Mitochondrial control of store-operated Ca2+ channels in cancer: Pharmacological implications
|
Villalobos, Carlos
|
|
2018
|
135 |
C |
p. 136-143
|
artikel
|
| 16 |
NAMPT: A pleiotropic modulator of monocytes and macrophages
|
Travelli, Cristina
|
|
2018
|
135 |
C |
p. 25-36
|
artikel
|
| 17 |
Naringenin as a potential immunomodulator in therapeutics
|
Zeng, Wenfeng
|
|
2018
|
135 |
C |
p. 122-126
|
artikel
|
| 18 |
Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
|
Gelosa, Paolo
|
|
2018
|
135 |
C |
p. 60-79
|
artikel
|
| 19 |
Pharmacologic targeting of the diabetic stem cell mobilopathy
|
Albiero, M.
|
|
2018
|
135 |
C |
p. 18-24
|
artikel
|
| 20 |
Post-translational modifications at the ATP-positioning G-loop that regulate protein kinase activity
|
Steinberg, Susan F.
|
|
2018
|
135 |
C |
p. 181-187
|
artikel
|
| 21 |
Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1–9) through an AT2R and Akt-dependent mechanism
|
Mendoza-Torres, Evelyn
|
|
2018
|
135 |
C |
p. 112-121
|
artikel
|
| 22 |
Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53
|
Zhao, Yikai
|
|
2018
|
135 |
C |
p. 49-59
|
artikel
|
| 23 |
Targeting molecular pathways in cancer stem cells by natural bioactive compounds
|
Cianciosi, Danila
|
|
2018
|
135 |
C |
p. 150-165
|
artikel
|
| 24 |
Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration?
|
Shirooie, Samira
|
|
2018
|
135 |
C |
p. 37-48
|
artikel
|
| 25 |
Targeting neurotrophin signaling in cancer: The renaissance
|
Griffin, Nathan
|
|
2018
|
135 |
C |
p. 12-17
|
artikel
|
| 26 |
Targeting oncogenic Raf protein-serine/threonine kinases in human cancers
|
Roskoski Jr., Robert
|
|
2018
|
135 |
C |
p. 239-258
|
artikel
|
| 27 |
The Blood Brain Barrier and BRAF inhibitors: Implications for patients with melanoma brain metastases
|
Smalley, Keiran S.M.
|
|
2018
|
135 |
C |
p. 265-267
|
artikel
|
| 28 |
Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis
|
Feng, Fan
|
|
2018
|
135 |
C |
p. 89-101
|
artikel
|
Tijdschrift beschrijving